TrialCell reports. Medicine2026
A randomized controlled trial of precision bezlotoxumab treatment for Clostridioides difficile infection.
Christos Psarrakis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it